A similar effect of EZH2 was observed in colorectal cancer, where targeting EZH2 in cancer cells also augmented the expression of CXCL9 and CXCL10 chemokines, affecting the infiltration of the tumor by effector T cells [92]. This evidence concerns the gene CXCL9 and cancer.